Abstract
| Lingua originale | English |
|---|---|
| pagine (da-a) | 135-149 |
| Numero di pagine | 15 |
| Rivista | Journal of Comparative Effectiveness Research |
| Volume | 2 |
| Stato di pubblicazione | Published - 2013 |
Fingerprint
All Science Journal Classification (ASJC) codes
- Health Policy
Cita questo
Comparing medical treatment in Crohn's disease. / Cottone, Mario.
In: Journal of Comparative Effectiveness Research, Vol. 2, 2013, pag. 135-149.Risultato della ricerca: Article
}
TY - JOUR
T1 - Comparing medical treatment in Crohn's disease
AU - Cottone, Mario
PY - 2013
Y1 - 2013
N2 - The drugs available for inflammatory bowel disease are aminosalicylates, antibiotics, steroids, immunosuppressors and biologics. The effectiveness of these drugs has been evaluated in many randomized clinical trials, mainly versus placebo. Few studies have been conducted comparing the different drugs among themselves, owing to the methodological problems raised by comparative trials, such as sample size and blindness. This review focuses mainly on the randomized clinical trials that have compared different treatments. Of course comparisons are mainly between drugs used in a particular setting (mild, moderate and severe disease). However, on many occasions there is no homogeneity in these clinical settings, and therefore the results are difficult to interpret
AB - The drugs available for inflammatory bowel disease are aminosalicylates, antibiotics, steroids, immunosuppressors and biologics. The effectiveness of these drugs has been evaluated in many randomized clinical trials, mainly versus placebo. Few studies have been conducted comparing the different drugs among themselves, owing to the methodological problems raised by comparative trials, such as sample size and blindness. This review focuses mainly on the randomized clinical trials that have compared different treatments. Of course comparisons are mainly between drugs used in a particular setting (mild, moderate and severe disease). However, on many occasions there is no homogeneity in these clinical settings, and therefore the results are difficult to interpret
UR - http://hdl.handle.net/10447/74789
M3 - Article
VL - 2
SP - 135
EP - 149
JO - Journal of Comparative Effectiveness Research
JF - Journal of Comparative Effectiveness Research
SN - 2042-6305
ER -